Internal Medicine, Hematology & Oncology · Trinity, FL
NPI
1427279611
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3611 Little Rd
Trinity, FL, 34655
Phone (727) 312-4300
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
69,248 services
Medicare patients, 2024
192
Average age 76
Drug cost, 2024
$7.9M
3,232 prescriptions
Company payments, 2025
$4,354
From 54 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sudhir Hansalia was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 14,793 times for 16 patients. In total Sudhir Hansalia billed 69,248 services in 114 codes, and Medicare paid $1.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 14,793 | 16 | $0.28 | $4,169 |
| 36415 Venipuncture Blood Collection | Office | 384 | 115 | $8.65 | $3,322 |
| 85025 Blood Count | Office | 371 | 107 | $7.61 | $2,823 |
| 99213 Office E&M - Established | Office | 228 | 106 | $67.04 | $15K |
| 96372 Injection Administration | Office | 167 | 31 | $10.75 | $1,796 |
| 96367 Intravenous Infusion, Hydration | Office | 122 | 18 | $21.15 | $2,580 |
| 99214 Office E&M - Established | Office | 120 | 74 | $96.89 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 113 | 76 | $13.02 | $1,471 |
| 96413 Chemotherapy Administration | Office | 100 | 18 | $96.35 | $9,635 |
| 96365 Intravenous Infusion, Hydration | Office | 90 | 34 | $47.30 | $4,257 |
| 80053 Clinical Chemistry | Office | 82 | 39 | $10.35 | $849 |
| 96375 Injection Administration | Office | 77 | 15 | $11.62 | $895 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 68 | 17 | $0.62 | $41.85 |
| 82728 Clinical Chemistry | Office | 66 | 47 | $13.36 | $882 |
| 82746 Clinical Chemistry | Office | 46 | 37 | $14.41 | $663 |
By year: 2022 $968K for 67,856 services; 2023 $894K for 53,618 services; 2024 $1.1M for 69,248 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 384 | 115 | $8.65 | $3,322 |
| 85025 Blood Count | 371 | 107 | $7.61 | $2,823 |
| 80053 Clinical Chemistry | 82 | 39 | $10.35 | $849 |
| 82728 Clinical Chemistry | 66 | 47 | $13.36 | $882 |
| 82746 Clinical Chemistry | 46 | 37 | $14.41 | $663 |
| 82607 Clinical Chemistry | 41 | 33 | $14.78 | $606 |
| 83615 Clinical Chemistry | 38 | 24 | $5.92 | $225 |
| 83540 Clinical Chemistry | 36 | 27 | $6.34 | $228 |
Medicare prescription drug claims, 2024
In 2024, the drug Sudhir Hansalia prescribed most often to Medicare patients was Dexamethasone Sodium Phosphate (Dexamethasone Sodium Phosp/Pf), with 221 prescriptions and refills. In total Sudhir Hansalia wrote 3,232 Medicare prescriptions that cost $7.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosp/Pf | 221 | 221 | 49 | $1,914 |
| Anastrozole Generic | 208 | 579 | 66 | $3,883 |
| Diphenhydramine Hcl Generic | 120 | 130 | 28 | $278 |
| Oxycodone Hcl Generic | 109 | 109 | 21 | $2,152 |
| Ondansetron Odt Ondansetron | 93 | 95 | 70 | $7,020 |
| Procrit Epoetin Alfa | 88 | 88 | 23 | $356K |
| Prochlorperazine Maleate Generic | 85 | 85 | 53 | $2,786 |
| Lenalidomide Generic | 85 | 85 | 12 | $1.1M |
| Retacrit Epoetin Alfa-Epbx | 81 | 81 | 19 | $89K |
| Hydroxyurea Generic | 76 | 188 | 24 | $2,847 |
| Granisetron Hcl Granisetron Hcl/Pf | 75 | 75 | 21 | $1,100 |
| Famotidine Famotidine/Pf | 71 | 82 | 19 | $113 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 68 | 72 | Under 11 | $745K |
| Prednisone Generic | 54 | 75 | 15 | $439 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 53 | 53 | 26 | $567 |
Brand drugs: 801 claims; generic drugs: 2,431 claims; opioid claims: 256.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sudhir Hansalia $4,354 ($4,354 in general payments such as food, travel and fees) from 54 companies. The largest payer was Novartis Pharmaceuticals Corporation with $837.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 21 | $837 |
| Celgene Corporation BMY | 10 | $273 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $257 |
| Pfizer Inc. PFE | 12 | $252 |
| Incyte Corporation INCY | 10 | $226 |
| Janssen Biotech, Inc. JNJ | 9 | $196 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $171 |
| Fennec Pharmaceuticals, Inc. FENC | 8 | $166 |
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $150 |
| GlaxoSmithKline, LLC. GSK | 6 | $147 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.